2024年6月最新影响因子数据已经更新，欢迎查询！ 如果您对期刊系统有任何需求或者问题，欢迎反馈给我们。
 |
| 基本信息 | 登录收藏 | |||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字 | Journal of Thoracic Oncology J THORAC ONCOL （此期刊被最新的JCR期刊SCIE收录） LetPub评分 9.2
50人评分
我要评分
声誉 9.9 影响力 8.6 速度 9.4 | |||||||||||||||||||||||||||||||
| 期刊ISSN | 1556-0864 | 微信扫码收藏此期刊 | ||||||||||||||||||||||||||||||
| E-ISSN | 1556-1380 | |||||||||||||||||||||||||||||||
| 2023-2024最新影响因子 （数据来源于搜索引擎） | 21 点击查看影响因子趋势图 | |||||||||||||||||||||||||||||||
| 实时影响因子 | 截止2024年10月29日：12.416 | |||||||||||||||||||||||||||||||
| 2023-2024自引率 | 4.30%点击查看自引率趋势图 | |||||||||||||||||||||||||||||||
| 五年影响因子 | 16.5 | |||||||||||||||||||||||||||||||
| JCI期刊引文指标 | 4.26 | |||||||||||||||||||||||||||||||
| h-index | 113 | |||||||||||||||||||||||||||||||
| CiteScore （ 2024年最新版） |
| |||||||||||||||||||||||||||||||
| 期刊简介 |
| |||||||||||||||||||||||||||||||
| 期刊官方网站 | http://www.jto.org/ | |||||||||||||||||||||||||||||||
| 期刊投稿网址 | https://www.editorialmanager.com/JTO | |||||||||||||||||||||||||||||||
| 期刊语言要求 | 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件，不仅能满足Journal of Thoracic Oncology的语言要求，还能让Journal of Thoracic Oncology编辑和审稿人得到更好的审稿体验，让稿件最大限度地被Journal of Thoracic Oncology编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）帮助作者准备稿件，已助力全球15万+作者顺利发表论文。部分发表范例可查看：服务好评 论文致谢 。
提交文稿 | |||||||||||||||||||||||||||||||
| 是否OA开放访问 | No | |||||||||||||||||||||||||||||||
| 通讯方式 | LIPPINCOTT WILLIAMS & WILKINS, 530 WALNUT ST, PHILADELPHIA, USA, PA, 19106-3621 | |||||||||||||||||||||||||||||||
| 出版商 | International Association for the Study of Lung Cancer | |||||||||||||||||||||||||||||||
| 涉及的研究方向 | 医学-呼吸系统 | |||||||||||||||||||||||||||||||
| 出版国家或地区 | UNITED STATES | |||||||||||||||||||||||||||||||
| 出版语言 | English | |||||||||||||||||||||||||||||||
| 出版周期 | Monthly | |||||||||||||||||||||||||||||||
| 出版年份 | 2006 | |||||||||||||||||||||||||||||||
| 年文章数 | 100点击查看年文章数趋势图 | |||||||||||||||||||||||||||||||
| Gold OA文章占比 | 83.71% | |||||||||||||||||||||||||||||||
| 研究类文章占比： 文章 ÷（文章 + 综述） | 88.00% | |||||||||||||||||||||||||||||||
| WOS期刊SCI分区 （ 2023-2024年最新版） | WOS分区等级：1区
| |||||||||||||||||||||||||||||||
| 中国科学院《国际期刊预警 名单（试行）》名单 | 2024年02月发布的2024版：不在预警名单中 2023年01月发布的2023版：不在预警名单中 2021年12月发布的2021版：不在预警名单中 2020年12月发布的2020版：不在预警名单中 | |||||||||||||||||||||||||||||||
| 中国科学院SCI期刊分区 （ 2023年12月最新升级版） | 点击查看中国科学院SCI期刊分区趋势图
| |||||||||||||||||||||||||||||||
| 中国科学院SCI期刊分区 （ 2022年12月升级版） |
| |||||||||||||||||||||||||||||||
| 中国科学院SCI期刊分区 （ 2021年12月旧的升级版） |
| |||||||||||||||||||||||||||||||
| SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月，原SCI撤销合并入SCIE，统称SCIE) Scopus (CiteScore) | |||||||||||||||||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1556-0864%5BISSN%5D | |||||||||||||||||||||||||||||||
| 平均审稿速度 | 网友分享经验： 一般,3-6周 | |||||||||||||||||||||||||||||||
| 平均录用比例 | 网友分享经验： 较易 | |||||||||||||||||||||||||||||||
| LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍，平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）后论文在Journal of Thoracic Oncology顺利发表。
快看看作者怎么说吧：服务好评 论文致谢 | |||||||||||||||||||||||||||||||
| 期刊常用信息链接 |
| |||||||||||||||||||||||||||||||
|
|
| |
| 中国学者近期发表的论文 | |
| 1. | Brief Report: Durvalumab After Chemoradiotherapy in Unresectable Stage III EGFR-Mutant NSCLC: A Post Hoc Subgroup Analysis From PACIFIC Author: Naidoo, Jarushka; Antonia, Scott; Wu, Yi-Long; Cho, Byoung Chul; Thiyagarajah, Piruntha; Mann, Helen; Newton, Michael; Faivre-Finn, Corinne Journal: JOURNAL OF THORACIC ONCOLOGY. 2023; Vol. 18, Issue 5, pp. 657-663. DOI: 10.1016/j.jtho.2023.02.009 PubMed DOI |
| 2. | Tislelizumab Versus Docetaxel in Patients With Previously Treated Advanced NSCLC (RATIONALE-303): A Phase 3, Open-Label, Randomized Controlled Trial Author: Zhou, Caicun; Huang, Dingzhi; Fan, Yun; Yu, Xinmin; Liu, Yunpeng; Shu, Yongqian; Ma, Zhiyong; Wang, Ziping; Cheng, Ying; Wang, Jie; Hu, Sheng; Liu, Zhihua; Poddubskaya, Elena; Disel, Umut; Akopov, Andrey; Dvorkin, Mikhail; Zheng, Wenjuan; Ma, Yiyuan; Wang, Yan; Li, Songzi; Yu, Cunjing; Rivalland, Gareth Journal: JOURNAL OF THORACIC ONCOLOGY. 2023; Vol. 18, Issue 1, pp. 93-105. DOI: 10.1016/j.jtho.2022.09.217 PubMed DOI |
| 3. | NEPTUNE: Phase 3 Study of First-Line Durvalumab Plus Tremelimumab in Patients With Metastatic NSCLC Author: de Castro Jr, Gilberto; Rizvi, Naiyer A.; Schmid, Peter; Syrigos, Konstantinos; Martin, Claudio; Yamamoto, Nobuyuki; Cheng, Ying; Moiseyenko, Vladimir; Summers, Yvonne; Vynnychenko, Ihor; Lee, Sung Yong; Bryl, Maciej; Zer, Alona; Erman, Mustafa; Timcheva, Constanta; Raja, Rajiv; Naicker, Kirsha; Scheuring, Urban; Walker, Jill; Mann, Helen; Chand, Vikram; Mok, Tony Journal: JOURNAL OF THORACIC ONCOLOGY. 2023; Vol. 18, Issue 1, pp. 106-119. DOI: 10.1016/j.jtho.2022.09.223 PubMed DOI |
| 4. | Adebrelimab (SHR-1316) in Combination With Chemotherapy as Perioperative Treatment in Patients With Resectable Stage II to III NSCLCs: An Open-Label, Multicenter, Phase 1b Trial Author: Yan, Wanpu; Zhong, Wen-Zhao; Liu, Yan-Hui; Chen, Qixun; Xing, Wenqun; Zhang, Qin; Liu, Lunxu; Ge, Di; Chen, Keneng; Yang, Fan; Lin, Xiang; Song, Li; Shi, Wei; Wu, Yi-Long Journal: JOURNAL OF THORACIC ONCOLOGY. 2023; Vol. 18, Issue 2, pp. 194-203. DOI: 10.1016/j.jtho.2022.09.222 PubMed DOI |
| 5. | First-Line Nivolumab Plus Ipilimumab With Chemotherapy Versus Chemotherapy Alone for Metastatic NSCLC in CheckMate 9LA: 3-Year Clinical Update and Outcomes in Patients With Brain Metastases or Select Somatic Mutations Author: Paz-Ares, Luis G.; Ciuleanu, Tudor-Eliade; Cobo, Manuel; Bennouna, Jaafar; Schenker, Michael; Cheng, Ying; Juan-Vidal, Oscar; Mizutani, Hideaki; Lingua, Alejo; Reyes-Cosmelli, Felipe; Reinmuth, Niels; Menezes, Juliana; Jassem, Jacek; Protsenko, Svetlana; Richardet, Eduardo; Felip, Enriqueta; Feeney, Kynan; Zurawski, Bogdan; Alexandru, Aurelia; Jimenez, Emmanuel de la Mora; Dakhil, Shaker; Lu, Shun; Reck, Martin; John, Thomas; Hu, Nan; Zhang, Xiaoqing; Sylvester, Judi; Eccles, Laura J.; Grootendorst, Diederik J.; Balli, David; Neely, Jaclyn; Carbone, David P. Journal: JOURNAL OF THORACIC ONCOLOGY. 2023; Vol. 18, Issue 2, pp. 204-222. DOI: 10.1016/j.jtho.2022.10.014 DOI |
| 6. | PTEN Loss Expands the Histopathologic Diversity and Lineage Plasticity of Lung Cancers Initiated by Rb1/Trp53 Deletion Author: Zhang, Letian; Zhu, Xiang; Liu, Congrong; Zhang, Bo; Zheng, Jie; Singh, Prashant K.; Bshara, Wiam; Wang, Jianmin; Gomez, Eduardo Cortes; Zhang, Xiaojing; Wang, Yanqing; Goodrich, David W. Journal: JOURNAL OF THORACIC ONCOLOGY. 2023; Vol. 18, Issue 3, pp. 324-338. DOI: 10.1016/j.jtho.2022.11.019 PubMed DOI |
| 7. | Respiratory and Cardiometabolic Comorbidities and Stages I to III NSCLC Survival: A Pooled Analysis From the International Lung Cancer Consortium Author: Garcia-Pardo, Miguel; Chang, Amy; Schmid, Sabine; Dong, Mei; Brown, M. Catherinen; Christiani, David; Tindel, Hilary Aurora; Brennan, Paul; Chen, Chu; Zhang, Jie; Ryan, Brid M.; Zaridze, David; Schabath, Matthew B.; Leal, Leticia Ferro; Reis, Rui Manuel; Tardon, Adonina; Fernandez-Tardon, Guillermo; Shete, Sanjay S.; Andrew, Angeline; Brenner, Hermann; Xu, Wei; Hung, Rayjean J.; Liu, Geoffrey Journal: JOURNAL OF THORACIC ONCOLOGY. 2023; Vol. 18, Issue 3, pp. 313-323. DOI: 10.1016/j.jtho.2022.10.020 PubMed DOI |
| 8. | Defining Morphologic Features of Invasion in Pulmonary Nonmucinous Adenocarcinoma With Lepidic Growth: A Proposal by the International Association for the Study of Lung Cancer Pathology Committee Author: Thunnissen, Erik; Beasley, Mary Beth; Borczuk, Alain; Dacic, Sanja; Kerr, Keith M.; Lissenberg-Witte, Birgit; Minami, Yuko; Nicholson, Andrew G.; Noguchi, Masayuki; Sholl, Lynette; Tsao, Ming-Sound; Le Quesne, John; Roden, Anja C.; Chung, Jin-Haeng; Yoshida, Akihiko; Moreira, Andre L.; Lantuejoul, Sylvie; Pelosi, Giuseppe; Poleri, Claudia; Hwang, David; Jain, Deepali; Travis, William D.; Brambilla, Elisabeth; Chen, Gang; Botling, Johan; Bubendorf, Lukas; Mino-Kenudson, Mari; Motoi, Noriko; Chou, Teh Ying; Papotti, Mauro; Yatabe, Yasushi; Cooper, Wendy; Invasion Working Group Journal: JOURNAL OF THORACIC ONCOLOGY. 2023; Vol. 18, Issue 4, pp. 447-462. DOI: 10.1016/j.jtho.2022.11.026 PubMed DOI |
| 9. | Expert Consensus Recommendations on Biomarker Testing in Metastatic and Nonmetastatic NSCLC in Asia Author: Mitsudomi, Tetsuya; Tan, Daniel; Yang, James Chih-Hsin; Ahn, Myung-Ju; Batra, Ullas; Cho, Byoung-Chul; Cornelio, Gerardo; Lim, Tony; Mok, Tony; Prabhash, Kumar; Reungwetwattana, Thanyanan; Ren, Sheng-Xiang; Singh, Navneet; Toyooka, Shinichi; Wu, Yi-Long; Yang, Pan-Chyr; Yatabe, Yasushi Journal: JOURNAL OF THORACIC ONCOLOGY. 2023; Vol. 18, Issue 4, pp. 436-446. DOI: 10.1016/j.jtho.2022.10.021 PubMed DOI |
| 10. | Impaired Cytolytic Activity and Loss of Clonal Neoantigens in Elderly Patients With Lung Adenocarcinoma Author: Zhihua Gong, Qingzhu Jia, Junying Chen, Xinwei Diao, Jianbao Gao, Xinxin Wang, Bo Zhu Journal: Journal of Thoracic Oncology, 2019, Vol., , DOI:10.1016/j.jtho.2019.01.024 DOI |
|
|
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2024 中国: LetPub上海 网站备案号：沪ICP备10217908号-1 
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
增值电信业务经营许可证：沪B2-20211595 网络文化经营许可证：沪网文[2023]2004-152号
礼翰商务信息咨询（上海）有限公司 办公地址：上海市徐汇区漕溪北路88号圣爱大厦1803室
安全保密
